Xvivo Perfusion AB (publ) (LON:0RKL)
London
· Delayed Price · Currency is GBP · Price in SEK 284.49
+2.29 (0.81%)
At close: Jun 27, 2025
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 683.75 million as of June 30, 2025. Its market cap has decreased by -35.16% in one year.
Market Cap
683.75M
Enterprise Value
661.75M
Revenue
65.93M
Ranking
n/a
PE Ratio
64.73
Stock Price
284.49
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 34.98M to 683.75M, an increase of 1,854.69%. That is a compound annual growth rate of 26.31%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 156.93B |
| GSK plc | 56.25B |
| Haleon | 33.64B |
| Smith & Nephew | 9.74B |
| ConvaTec Group | 5.90B |
| Hikma Pharmaceuticals | 4.38B |
| HUTCHMED (China) | 1.87B |
| Indivior | 1.35B |